Sichuan Kelun Pharmaceutical Co., Ltd. (SHE: 002422)

Market Cap	46.77B
Revenue (ttm)	22.50B
Net Income (ttm)	2.96B
Shares Out	1.59B
EPS (ttm)	1.89
PE Ratio	15.57
Forward PE	15.45
Dividend	0.52 (1.74%)
Ex-Dividend Date	Oct 23, 2024

Volume	12,883,328
Open	30.48
Previous Close	30.32
Day's Range	29.84 - 30.48
52-Week Range	21.60 - 35.49
Beta	0.05
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 24, 2025

About Sichuan Kelun Pharmaceutical

Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, manufactures, distributes, and sells pharmaceutical products in China. It offers infusion products; oral medication and other dosage form; plastic ampoule and powder liquid dual chamber infusion bag; medical devices, such as infusion set, injection syringes, detained needles, nebulizer, and blood sampling; and over-the-counter products. The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical Co., Ltd. is a subsidiary of Sic...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1996
• Employees: 19,798
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002422

Financial Performance

In 2023, Sichuan Kelun Pharmaceutical's revenue was 21.45 billion, an increase of 12.69% compared to the previous year's 19.04 billion. Earnings were 2.46 billion, an increase of 44.03%.